INTERCEPT BLOOD SYSTEM FOR PLATELETS
PHOTOCHEMICAL TREATMENT (PCT) OF PLATELETS
USING AMOTOSALEN HYDROCHLORIDE AND UVA LIGHT
INTERCEPT Blood System for Platelets
The INTERCEPT Blood System for platelets is a Class III medical device that is intended
for the ex vivo preparation and storage of whole blood-derived and apheresis platelets.
The system is used to inactivate a broad spectrum of viruses, bacteria, and parasites as
well as contaminating donor leukocytes in platelet components. This process is intended
to reduce the risk of transfusion-associated transmission of viruses, bacteria, and
parasites, prevent transfusion-associated graft versus host disease, and may also reduce
the risk of other adverse effects due to transfusion of contaminating donor leukocytes.
The device uses amotosalen HCl (a photoactive compound) and long-wavelength
ultraviolet (UVA) illumination to photochemically treat platelet components.
INTERCEPT Platelet Processing Sets
The INTERCEPT Blood System for platelets is a sterile, non-pyrogenic fluid path
integrated disposable plastic processing set. The INTERCEPT Platelet Processing Sets
consist of small volume (SV), large volume (LV) and dual storage containers (DS)
disposables. The INTERCEPT processing sets for large volume platelet concentrates and
small volume platelet concentrates are each provided as four integral containers in a
sealed over-wrap. The INTERCEPT platelet processing set with dual storage containers
is provided as five integral containers in a sealed over-wrap. Platelets suspended in
plasma with or without additive solution (InterSol Solution) can be processed with this
system. Platelets suspended in 100% plasma must be processed using only the LV
processing set. When using InterSol, either the LV, DS or SV processing sets can be
used and the plasma to InterSol ratio in the suspension medium needs to be
approximately 35%/65%. Platelets flow through the amotosalen container into the
illumination container. The nominal concentration of amotosalen in the platelet mixture
prior to illumination is 150 μM. Photoactivation is provided by the INTERCEPT
Illuminator. This ancillary Class I device is microprocessor controlled and delivers a
target UVA treatment of 3 J/cm2. Residual amotosalen and free photoproducts are
reduced to low levels by exposure to a compound adsorption device (CAD), before
transfer of the treated platelets to a storage container for release.
Amotosalen Hydrochloride
Amotosalen HCl is a synthetic psoralen compound that reversibly intercalates into the
helical regions of DNA and RNA. Upon illumination with UVA light at 320 to 400 nm,
amotosalen forms covalent bonds with pyrimidine bases in nucleic acid.The genomes of
pathogens and leukocytes cross-linked in this manner can no longer function or replicate.
No in vivo pharmacological effect of residual amotosalen is intended.
InterSol Solution
InterSol Solution (provided separately) is an isotonic buffered salt solution developed
specifically for processing and storage of platelets treated with the INTERCEPT Blood
System.
INTERCEPT Platelets
Platelets suspended in 35% plasma and 65% InterSol that have been processed using the
INTERCEPT Blood System may be stored for up to 7 days from time of collection at
20°C to 24ºC with continuous gentle agitation according to applicable blood banking
procedures. Any extension of platelet storage time should be evaluated and validated
according to local blood bank procedures.
Platelets suspended in 100% plasma that have been processed using the INTERCEPT
Blood System may be stored for up to 5 days from time of collection at 20°C to 24ºC
with continuous gentle agitation according to applicable blood banking procedures.
Treatment of platelet components with the INTERCEPT Blood System does not cause
substantial differences in pH, lactate concentration, platelet count, morphology score,
glucose concentration, aggregation, secretory and total adenosine triphosphate
concentration, extent of shape change, or platelet hypotonic shock response compared to
untreated platelet components.
Technical Data Sheets section page 1 of 7 
|